SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amcis informs about presentation

14 Nov 2024 Evaluate

Pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Dishman Carbogen Amcis has informed that it enclosed Presentation on financial result for the second quarter and half year ended 30th September, 2024 to be made to Analyst and Investors. The aforesaid presentation is also being hosted on the website of the Company, www.imdcal.com in accordance with the Regulations 46 and 62 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Dishman Carbogen Amc Share Price

167.55 -1.05 (-0.62%)
20-Apr-2026 15:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.70
Dr. Reddys Lab 1231.60
Cipla 1230.10
Zydus Lifesciences 938.00
Lupin 2328.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×